Aeglea BioTherapeutics, Inc. entered into a Securities Purchase Agreement for a private placement with certain investors, purchasing shares of common stock and preferred stock for a total of $180.0 million.
AI Assistant
SPYRE THERAPEUTICS INC
2023
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.